India’s First-Ever Central Government–Private Healthcare Collaboration Launched at Metro Railway’s Tapan Sinha Memorial Hospital
DSIJ Intelligence-1 / 14 Aug 2025/ Categories: Mindshare, Trending
The stock is up by 47 per cent from its 52-week low of Rs 99.95 per share.
In a historic step for India’s healthcare sector, Metro Railway Kolkata, a central government entity under Indian Railways, has entered into its first-ever partnership with Nephro Care India Ltd, a leading provider of comprehensive 360° renal care under the PPP model. This unique collaboration, the first of its kind in India, was inaugurated at Tapan Sinha Memorial Hospital, operated by Metro Railway. The initiative aims to combine the extensive reach and infrastructure of Metro Railway with the specialised medical expertise of Nephro Care India Ltd, led by eminent nephrologist Dr. Pratim Sengupta.
Advertisement:
25% OFF on DSIJ's Stock Recommendations
Nephro Care India has a clear vision — to serve 1 million patients through 300 advanced renal care units across the nation. The partnership will ensure that world-class kidney care services are accessible to a larger segment of the population, leveraging Metro Railway’s central location and connectivity to reach patients more effectively. By integrating public infrastructure with private medical innovation, this collaboration sets a new benchmark for public–private partnerships in India’s healthcare landscape. It symbolises a shared commitment to delivering affordable, accessible and quality renal care to the people of Kolkata and beyond.
About the Company
Nephro Care India Ltd (NCIL), incorporated in 2014, is a Kolkata-based healthcare provider specialising in comprehensive kidney-related disease treatment, offering both clinical and lifestyle solutions for renal insufficiency with a focus on non-invasive services. Utilising a multi-dimensional patient engagement framework, NCIL provides programs like Mukti, Home Dialysis and Home Care, operating on a hub-and-spoke model where each clinic functions independently with advanced infrastructure, ensuring comprehensive care and patient rehabilitation.
DSIJ’s ‘Micro Marvel' service recommends micro-cap stocks with the potential to grow multifold in long run. If this interests you, download the service details here.
The company has a market cap of over Rs 200 crore and is debt-free as of March 2025. The stock is up by 47 per cent from its 52-week low of Rs 99.95 per share.
Disclaimer: The article is for informational purposes only and not investment advice.